Adomeglivant, (+) -

Adomeglivant ((+) -LY2409021) is a potent and selective glucagon receptor antagonist. It effectively reduces blood glucose levels in both healthy subjects and type 2 diabetes patients, making it a valuable tool for in vivo metabolic studies and in vitro investigations of glucagon receptor signaling pathways.